The proportion of patients with symptomatic severe aortic stenosis treated by transcatheter aortic valve replacement (TAVR) is increasing, driven by favorable outcomes from randomized trials and current valve guidelines recommendations. Despite device and technique improvements having reduced procedural morbidities, complications during or immediately after TAVR still carries significant mortality risk.
Reference: Minimum requirements in emergency kits for bailout strategies in TAVR complications. Gennari M, Tang GHL, Taramasso M, Russo G, Haager PK, Barbanti M, Tagliari AP, Maisano F. J Card Surg. 2022 Mar 6